RAMP2 and chondrosarcoma: Additionally, elevated serum levels of RAMP2-AS1 were correlated with advanced stages and metastatic characteristics in chondrosarcoma patients, suggesting that RAMP2-AS1 emerges as a novel therapeutic target for chondrosarcoma within exosomes [23].